Safety and Efficacy of OMS302 in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR)
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the use of OMS302 (the study drug) in
individuals undergoing Cataract Extraction with Lens Replacement (CELR) surgery is safe and
effective at maintaining an adequately dilated pupil during surgery and reducing
post-operative symptoms of discomfort (such as eye pain and irritation).